ºÐÀÚÁø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography
»óǰÄÚµå : 1672710
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀåÀº 2025³â¿¡´Â 183¾ï 6,000¸¸ ´Þ·¯¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2032³â¿¡´Â 416¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025-2032³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 12.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 183¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 12.40% 2032³â ±Ý¾× ¿¹Ãø 416¾ï 3,000¸¸ ´Þ·¯
±×¸². ºÐÀÚÁø´Ü ½ÃÀå Á¡À¯À²(%), 2025³â, Áö¿ªº°
Molecular Diagnostics Market-IMG1

ºÐÀÚÁø´ÜÇÐÀº »ý¹°ÇÐÀû ¸¶Ä¿(¹ÙÀÌ¿À¸¶Ä¿)¸¦ ºÐÀÚ ¼öÁØ¿¡¼­ ºÐ¼®Çϰí Áúº´ °Ë»ç, À§Çè ¿¹Ãø, »õ·Î¿î Ä¡·á ¿É¼ÇÀ» ½Äº°ÇÏ´Â ¹ßÀüÀûÀÎ ºÎ¹®ÀÔ´Ï´Ù. ºÐÀÚÁø´ÜÇÐÀº Çö´ëÀÇ·á¿¡ À־ ±âº»ÀûÀÎ µµ±¸°¡ µÇ¾î ÀÓ»óÀǰ¡ Áúº´À» °ËÃ⡤¸ð´ÏÅ͸µÇϰí Ä¡·á¹æÄ§À» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. DNA ½ÃÄö½Ì ¹× ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)°ú °°Àº ±â¼ú¿¡ ÀÇÇØ ¹ÙÀÌ¿À¸¶Ä¿¸¦ °ËÃâÇÏ´Â ´É·ÂÀº ÀÇ·á °Ë»ç¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ È¯ÀÚÀÇ °á°ú¸¦ Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ºÐÀÚÁø´Ü±â¼úÀÇ Áøº¸´Â À¯ÀüÀÚ ½ÃÄö½ÌÀÇ ºñ¿ëÀúÇÏ¿Í ÇÔ²² °¨¿°Áõ °Ë»ç, Á¾¾çÇÐ, ¸ÂÃãÇü ÀÇ·á µî ´Ù¾çÇÑ ¿ëµµ ºÎ¹®¿¡¼­ÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ßÀÇ Áö¼ÓÀº ºÐ¼® ´É·ÂÀ» ´õ¿í È®´ëÇÏ°í ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀåÀº ¿©·¯ ¿äÀε鿡 ÀÇÇØ °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼¼°è¿¡¼­ ¸¸¼º Áúȯ°ú °¨¿°ÀÌ Áõ°¡Çϰí ÷´Ü Áø´Ü ±â¼úÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´Ü °Ë»ç´Â ±âÁ¸ ¹æ¹ý¿¡ ºñÇØ ´õ ºü¸£°í Á¤È®ÇÏ°Ô Áúº´À» ¹ß°ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐÀÚ °Ë»ç´Â °³º° ȯÀÚ¿¡°Ô °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ» È®ÀÎÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ¸ÂÃãÇü ÀÇ·á ¹× µ¿¹ÝÀÚ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ Áß¿äÇÑ ÃËÁø¿äÀÎÀÌ µÇ¾ú½À´Ï´Ù. °í¼º´É ¹× ½ºÅ©¸®´×, ÀÚµ¿È­µÈ ¿öÅ©Ç÷οì ÇÁ·Î¼¼½º, ºÐ»êÈ­µÈ °Ë»ç ȯ°æÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±â¼úÀÇ ¹ßÀüÀ¸·Î ºÐÀÚÁø´Ü ´É·ÂÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª °Ë»ç Àåºñ ºñ¿ëÀÌ ³ô°í ¼÷·Ã ³ëµ¿ÀÚ ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ºñ¿ëÀÇ Áö¼ÓÀûÀÎ °¨¼Ò¿Í ÈÞ´ë¿ë ¹× »ç¿ëÇϱ⠽¬¿î ÀåºñÀÇ °³¹ßÀº ƯÈ÷ ºÐ»êÇü Æ÷ÀÎÆ® ¿Àºê Äɾî ȯ°æ¿¡¼­ »õ·Î¿î ¿ëµµ ºÎ¹®ÀÇ ±âȸ¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.

´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª¿¡ ÀÇÇÑ Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN NV, Roche Diagnostics µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå, Á¦Ç° À¯Çüº°(2025-2032³â), 10¾ï ´Þ·¯

Á¦5Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå, ¿ëµµº°(2025-2032³â), 10¾ï ´Þ·¯

Á¦6Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2025-2032³â), 10¾ï ´Þ·¯

Á¦7Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå, Áö¿ªº°(2020-2032³â), 10¾ï ´Þ·¯

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ

Á¦10Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Molecular Diagnostics Market is estimated to be valued at USD 18.36 Bn in 2025 and is expected to reach USD 41.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.36 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.40% 2032 Value Projection: USD 41.63 Bn
Figure. Molecular Diagnostics Market Share (%), By Region 2025
Molecular Diagnostics Market - IMG1

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics:

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study:

This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Detailed Segmentation-

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

2. MARKET PURVIEW

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

4. Global Molecular Diagnostics Market, By Product Type, 2025-2032, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2025-2032, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2025-2032, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2020 - 2032, Value (USD Bn)

8. COMPETITIVE LANDSCAPE

9. Analyst Recommendations

10. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â